- Hugot JP, Laurent-Puig P, Gower-Rousseau C, Oison J, Lee J, Beaugerie L, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379:821-3.
- Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, et al. Two-stage genome-wide search in inflammatory bowel disease: evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996; 14:199-202.
- The IBD International Genetics Consortium. International collaboration provides convincing linkage replication in complex disease through analysis of a large pooled data set: Crohn disease and chromosome 16. Am J Hum Genet 2001:68;1165-71.
- Hampe J, Cuthbert A, Croucher P, Mirza M, Mascheietti S, Fisher S, et al. Association between insertion in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001:357:1925-8.
- Ogura Y, Bonen D, Inohara N, Nicolae D, Chen F, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001:411:603-6.
- Hugot J-P, Chamaillard M, Zouali H, Lesage S, Cezard L-P, Belaiches J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001:411 : 599-603.
- Paavola P, Heliö T, Kiuru M, Halme L, Turunen U, Terwillinger J, et al. Genetic analysis in Finnish families with inflammatory bowel disease supports linkage to chromosome 3p21. Eur J Hum Genet 2001:9:328-34.
- Rioux JD, Silverberg MS, DaIy MJ, Steinhart A, McLeod R, Griffiths A, et al. Genome wide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000;66:1863-70.
- Lindberg E, Tysk C, Andersso n K, Järnerot G. Smoking and inflammatory bowel disease. A case-control study. Gut 1988;29: 352-7.
- Sandborn WJ, Tremaine WJ, Offord KP, Lawson GM, Petersen BT, Bans KP, et al. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomised double-blind, placebo-controlled trial. Ann Intern Med 1997;126:364-71.
- Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001;120:1093-9.
- Shanahan F, Duerr RH, Rotter JI, Yang H, Sutherland L, McElree C, et al. Neutrophil autoantibodies in ulcerative colitis: familial aggregatio n and genetic heterogeneity. Gastroenterolog y 1992:103:456-61
- Seibold F, Slametschka D, Gregor M, Weber P. Neutrophil antibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1994;107:532-6.
- Lee JC, Lennard-Jones JE, Cambridge G. Antineutrophil antibodies in familial inflammatory bowel disease. Gastroenterology 1995:108:428-33.
- Quintan JF, Sendid B, Reumax D, Duthilleul P, Cortot A, Grandbastien B, et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease; prevalence and diagnostic role. Gut 1998;42:788-91.
- Sutton CL, Yang H, Li Z, Rotter JI, Targan SR, Braun J. Familial expession of anti-Sacchammyce s cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000;46:58-63.
- Seibold F, Stich O, Hufhagl R, Kamil S, Scheurlen M. AntiSaccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol 2001 ;36:196-201.
- Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989;24 Suppl:2-6.
- Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the working party for the world congresse s of gastroenterolog y Vienna 1998. Inflammatory Bowel Diseases 2000;6:8-15.
- Savige J, Gillis D, Benson E, Davies D, Esnault V, FaIk R. International consensus statement on testing and reporting of antineutrophi 1 cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999:111:507-13.
- Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen A, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84-8.
- Monsen U, Bernell O, Johansson C, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. Scand J Gastroenterol 1991;26:302-6.
- Carbonnel F, Macaigne G, Beaugerie L, Gendre JP, Cosnes J. Crohn's disease severity in familial sporadic cases Gut 1999;44: 91-9.
- Peelers M, Nevens H, Baert F, Hiele M, de Mayer AM, Vlietinck R, et al. Familial aggregation in Crohn's disease: increased ageadjusted risk and concordance in clinical characteristics. Gastroenterology 1996;! 11:597 -603.
- Satsangi J, Grootscholten C, Holt H, Jewel! D. Clinical patterns of familial inflammatory bowel disease. Gut 1996;38:738-41.
- Colombel J-F, Grandbastien B, Gower-Rousseau C, Plegat S, Evrard JP, Dupas JL, et al. Clinical characteristics of Crohn's disease in 72 families. Gastroenterolog y 1996;111:604-7.
- Polito JM, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterolog y 1996;111: 580-6.
- Cottone M, Brognola C, Rosselli M, Oliva L, Belloni C, Cipolle C, et al. Relationship between site of disease and familial occurrence in Crohn's disease. Dig Dis Sei 1997;42:129-32.
- Monsen U, Broström O, Norden val 1 B, Sörstad J, Hellers G. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol 1987;22: 214-8.
- Lee JCW, Bridger S, McGregor C, Macpherson AJS, LennardJones JE. Why children with inflammatory bowel disease are diagnosed at a younger age than their affected parent. Gut 1999:44:808-11.
- Yang H, McElree C, Roth M-P, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 1993;34:517-24.
- Orholm M, Fonager K, Sorensen T. Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol 1999;94: 3236-8.
- Vermeire S, Joossens S, Peelers M, Monsuur F, Marien G, Bossuyt X, et al. Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assay in inflammatory bowel disease. Gastroenterology 2001:120:827-33.
- Oudkerk Pool M, Ellerbroek PM, Ridwan BU, Goldschmeding R, von Blomberg BM, Pena AS, et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993:34:46-50.
- Peelers M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyce s cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol 2001;96:730-4.
Familial and Sporadic Inflammatory Bowel Disease: Comparison of Clinical Features and Serological Markers in a Genetically Homogeneous Population
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.